Interferon-α elevates pulmonary blood pressure in sheep—the role of thromboxane cascade

[1]  K. Kubo,et al.  Effect of post-treatment with granulocyte colony-stimulating factor on endotoxin-induced lung injury in sheep. , 1998, Experimental lung research.

[2]  R. Turnage,et al.  Thromboxane A2 mediates increased pulmonary microvascular permeability after intestinal reperfusion. , 1997, Journal of applied physiology.

[3]  A. Franchi,et al.  Role of interferon-α in arachidonic acid metabolism by the rat uteri from spayed animals: Effect of 17β-estradiol , 1995 .

[4]  H. Nawata,et al.  Interstitial pneumonia caused by interferon‐α in chronic myelogenous leukemia , 1994 .

[5]  T. Honda,et al.  Effects of ONO-5046, a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep. , 1994, Journal of applied physiology.

[6]  N. Hizawa,et al.  A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration. , 1994, Internal medicine.

[7]  T. Vial,et al.  Clinical Toxicity of the Interferons , 1994, Drug safety.

[8]  K. Kubo,et al.  Granulocyte colony-stimulating factor does not exacerbate endotoxin-induced lung injury in sheep. , 1993, The American review of respiratory disease.

[9]  Y. Adachi,et al.  Interstitial pneumonitis and interferon-alfa. , 1993, BMJ.

[10]  J. Heffner,et al.  Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury. , 1993, Journal of applied physiology.

[11]  K. Kubo,et al.  Effects of thromboxane synthase inhibition on tumor necrosis factor-induced lung injury in sheep. , 1992, Journal of applied physiology.

[12]  K. Kubo,et al.  Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep. , 1992, The American review of respiratory disease.

[13]  J. Hoofnagle,et al.  Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. , 1991, Annals of internal medicine.

[14]  J. Kelley.  Cytokines of the lung. , 1992, The American review of respiratory disease.

[15]  L. Fleisher,et al.  Modulation of arachidonic acid metabolism by bovine alveolar macrophages exposed to interferons and lipopolysaccharide. , 1990, American journal of veterinary research.

[16]  P. Staeheli.  Interferon-induced proteins and the antiviral state. , 1990, Advances in virus research.

[17]  L. Rubin,et al.  Effects of a Thromboxane A2 Analogue and Prostacyclin on Lung Fluid Balance in Newborn Lambs , 1989, Circulation research.

[18]  C. Valeri,et al.  Thromboxane A2 Mediates Increased Pulmonary Microvascular Permeability Following Limb Ischemia , 1989, Circulation research.

[19]  L. Marshall,et al.  Release of arachidonic acid metabolites by human monocytes or lymphocytes: effect of treatment with interferon on stimulation by phorbol ester or calcium ionophore. , 1987, Clinical immunology and immunopathology.

[20]  K. Zoon,et al.  Differential effects of interferon-alpha and interferon-gamma on interleukin 1 secretion by monocytes. , 1987, Journal of immunology.

[21]  M. Clemens.  15th annual UCLA symposium. Abstracts: Interferons as cell growth inhibitors and antitumor factors. , 1987, Journal of cellular biochemistry. Supplement.

[22]  N. Omawari,et al.  Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046). , 1986, Japanese journal of pharmacology.

[23]  K. Kubo,et al.  Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. , 1985, The American review of respiratory disease.

[24]  B. Rouse,et al.  Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. , 1984, Science.

[25]  J. Vilček,et al.  Interferons and the immune system , 1984 .

[26]  J. Gutterman,et al.  Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. , 1983, Blood.

[27]  M. Inoue,et al.  Elevation of Thromboxane B2 Levels in Patients with Classic and Variant Angina Pectoris , 1981, Circulation.

[28]  H. Strander,et al.  INTERFERON THERAPY IN MYELOMATOSIS , 1979, The Lancet.

[29]  T. Merigan,et al.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. , 1976, The New England journal of medicine.

[30]  K. Brigham,et al.  Preparation of chronic lung lymph fistulas in sheep. , 1975, The Journal of surgical research.

[31]  S. Hansen,et al.  Letter: Myopathies: the neurogenic hypothesis. , 1974, Lancet.

[32]  B. Jaffe,et al.  Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma. , 1973, The Journal of clinical investigation.

[33]  J. Lindenmann,et al.  Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.